I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

More than a dozen lawsuits have been filed on behalf of weight-loss drug users who claim that popular weight-loss medications ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

Ozempic was originally approved by the Food and Drug Administration (FDA) to treat people with Type 2 diabetes, who risk ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Nationwide, more than a dozen lawsuits have been filed alleging vision loss after taking Ozempic or Wegovy, said Jason Goldstein, senior litigation counsel with Parker Waichman LLP, who represents ...